About Saibogen
Saibogen is a blood intelligence company and a joint venture of Hologen and Sysmex. It applies Hologen’s Large Medicine Models to the data that Sysmex hematology analyzers capture in every routine blood count, giving researchers and clinicians a richer view of each patient from tests already being run, with no new instruments, reagents or samples.
Our ambition
Every day, millions of people have a blood count, and in each one an analyzer measures tens of thousands of cells with remarkable precision. We believe that measurement is one of the richest in medicine, and that precision and access belong together. So we are building AI that learns from all of it, one validated application at a time, starting with research. We show our work, and we let the evidence set the pace.
A world where a routine blood test is one of the most informative in medicine, and every patient’s care is guided by more of their own biology.
Founding partners
Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of “Together for a better healthcare journey.”* Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. For more information about Sysmex, please visit www.sysmex.co.jp/en/.
*“Healthcare journey” is a trademark of Sysmex Corporation, registered in Japan.
Hologen is a frontier AI company developing Large Medicine Models. These multimodal models are trained on large-scale, real-world clinical data from healthcare partners and learn the underlying biology of each patient. This allows Hologen to make more accurate diagnoses, understand how disease progresses, predict response to treatment and model patient outcomes. The company applies these models across diagnostics, drug development and health systems, and is advancing its own portfolio of therapeutic programmes. Hologen works with leading healthcare, pharmaceutical and technology companies to bring better diagnosis and effective medicines to patients sooner.
For more information, visit www.hologen.ai.
Saibō is Japanese for “cell.” Gen comes from generative AI. Saibogen is pronounced SY-boh-gen.
Join us
We’re building a team at the meeting point of AI and hematology. Follow Saibogen on LinkedIn for roles as they open.